Last quarter (Q4 2023), Novavax's total revenue was $291.34M, a decrease of -18.48% from the same quarter last year. In Q4, Novavax's net income was $-178.39M. See Novavax’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 983.71M	$ 983.71M	$ 1.98B	$ 1.15B	$ 475.60M	$ 18.66M
Cost of Revenue	$ 365.35M	$ 343.77M	$ -79.21M	-	-	-
Gross Profit	$ 605.85M	$ 639.94M	$ 1.98B	$ 1.15B	-	-
Operating Expense	$ 1.23B	$ 1.21B	$ 1.72B	$ 2.83B	$ 892.32M	$ 148.26M
Operating Income	$ -566.51M	$ -566.51M	$ -644.74M	$ -1.69B	$ -416.72M	$ -129.60M
Net Non Operating Interest Income Expense	$ -14.42M	$ -14.42M	$ -19.88M	$ -19.76M	$ -15.14M	$ -13.61M
Other Income Expense	$ -37.90M	$ -37.90M	$ 891.67M	$ 8.20M	$ 13.61M	$ 10.52M
Pretax Income	$ -543.03M	$ -543.03M	$ -653.65M	$ -1.71B	$ -418.26M	$ -132.69M
Tax Provision	$ 2.03M	$ 2.03M	$ 4.29M	$ 29.21M	$ 0.00	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -545.06M	$ -545.06M	$ -657.94M	$ -1.74B	$ -418.26M	$ -132.69M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 433.66M	$ 1.55B	$ 1.64B	$ 2.83B	$ 892.32M	$ 148.26M
Net Income From Continuing And Discontinued Operation	$ -545.06M	$ -545.06M	$ -657.94M	$ -1.74B	$ -418.26M	$ -132.69M
Normalized Income	$ 89.76M	-	$ 386.26M	-	$ -419.27M	$ -143.22M
Interest Expense	-	-	-	-	$ 15.14M	$ 12.19M
EBIT	$ -354.86M	$ -518.84M	$ -621.23M	$ -1.71B	$ -403.11M	$ -120.51M
EBITDA	$ -324.42M	$ -477.61M	$ -592.17M	$ -1.69B	$ -398.23M	$ -114.83M

Currency in USD

Novavax Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing